Evaluation of a proactive cardiovascular risk screening program after preeclampsia: the Queen of Hearts study

28 August 2023 (08:15 - 08:50)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Mrs Emma Janssen

Maastricht University Medical Centre (MUMC), Maastricht (Netherlands (The))

5 More presentations in this session

Presentation thumbnail

Predicting the death caused by cardiovascular and/or cerebrovascular disease within 7 years follow-up using machine learning models

Miss K. Tsarapatsani (Ioannina, GR)

Abstract Slides Video

Presentation thumbnail

Ideal cardiovascular health metrics and cardiovascular mortality in patients with renal insufficiency

Professor R. Huang (Beijing, CN)

Abstract Slides Video

Presentation thumbnail

Updating cardiovascular disease risk prediction equations to account for lipid lowering treatment drop-in during follow up: a national data-linkage cohort

Miss J. Liang (Auckland, NZ)

Abstract Slides Video

Presentation thumbnail

Machine learning-based prediction of 30-day major adverse cardiac and cerebrovascular events in non-cardiac surgery patients

Doctor H. Ahn (Seongnam, KR)

Abstract Slides Video

Presentation thumbnail

Genetic risk score and epicardial adipose tissue: the new tools with impact on cardiovascular risk assessment

Doctor M. Temtem (Funchal, PT)

Abstract Slides Video

Access the full session

Session thumbnail

Cardiovascular risk assessment: scores (3)

The Event

Event poster

ESC Congress 2023

28 August 2023 08:15 CET

You may be interested in

Congress Presentation

Subclinical atherosclerosis in women who have had preeclampsia: a systematic review and meta analysis

Congress Presentation

Long-term cardiovascular risk of pre-eclampsia

Congress Presentation

Preeclampsia: who is at risk and how to manage?

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources